1984 was adopted at the 7th meeting of the Standing Committee of the 6th NPC on September 20th, and shall be implemented as of July 20th, 1985. 2065438+The second amendment of the 14th session of the 12th the NPC Standing Committee on April 24th, 2005.
2065438+0818122 October, the revised draft of the Drug Administration Law was submitted to the National People's Congress Standing Committee (NPCSC) for deliberation, which will comprehensively increase the penalties for the production and sale of counterfeit drugs and inferior drugs.
Legal basis: Drug Administration Law of People's Republic of China (PRC).
Article 1 This Law is formulated with a view to strengthening drug administration, ensuring drug quality, safeguarding the safety and legitimate rights and interests of the public in drug use, and protecting and promoting public health.
Article 2 This Law shall apply to the research, production, trading, use, supervision and administration of drugs within the territory of People's Republic of China (PRC).
Drugs mentioned in this Law refer to substances used for preventing, treating and diagnosing human diseases, purposefully regulating human physiological functions, and specifying indications or functional indications, usage and dosage, including traditional Chinese medicines, chemicals and biological products.
Article 3 Drug management should focus on people's health, adhere to the principles of risk management, whole-process control and social governance, establish a scientific and strict supervision and management system, comprehensively improve the quality of drugs, and ensure the safety, effectiveness and accessibility of drugs.